Eosinophil to platelet ratio can predict acute exacerbation of COPD
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-01-26 23:30 GMT | Update On 2024-01-27 06:57 GMT
Advertisement
In a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease identified eosinophil to platelet ratio (EPR) as a potential predictor of adverse events in patients experiencing acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
A comprehensive retrospective was conducted at Dalian Municipal Friendship Hospital with the analysis of records that spanned from January 2018 to December 2020 and included a total of 508 patients (316 male, 192 female) with AECOPD. The key goal was to establish a correlation between clinical characteristics and EPR with a cutoff value of 0.755.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.